2-(Benzylmethylamino)ethylmethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridin-3,5-dicarboxylatmonohydrochlorid

Nicardipine Hydrochloride

HCID 41114CAS 54527-84-3

Grundinformationen

Standard-SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl
InChIKey
AIKVCUNQWYTVTO-UHFFFAOYSA-N
Summenformel
C26H30ClN3O6
Durchschnittliche Molmasse
516 g/mol
Monoisotopische Masse
515,18231336

Überblick

Nicardipine hydrochloride is a dihydropyridine. It has a role as a geroprotector.

Namen und Bezeichner

Bevorzugter Name
Nicardipine Hydrochloride
IUPAC
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
Lokaler Name
2-(Benzylmethylamino)ethylmethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridin-3,5-dicarboxylatmonohydrochlorid
Englischer Name
Nicardipine hydrochloride
Summenformel
C26H30ClN3O6
Molmasse
515.99

Namen und Synonyme

NICARDIPINE HYDROCHLORIDE54527-84-3Nicardipine HClLoxenPerdipineNicodelPerdipinaYC-93VasonaseCardene SRBarizinCardepine
Weitere Namen anzeigen
Naratriptan HCldafildaganlincilVasonas
DacarelLecibraLecibralLescodilNerdipinaNicapressNicardalNicarpin

Datenbank-Bezeichner

CAS
54527-84-3、69441-18-5
PubChem CID
41114
DTXSID
DTXSID9046992
ChEMBL
CHEMBL1200326、CHEMBL3199626
ChEBI
CHEBI:7551
UNII
K5BC5011K3
EC Number
259-198-4、274-007-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
114 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
10
Schwere Atome
36

Experimentelle und physikochemische Eigenschaften

Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section211.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
176 · 176-1780C
storage temp.
2 · 2-8°C
Löslichkeit
1 mg/mL · DMSO: ~1 mg/mL
Aggregatzustand
powder
Farbe
yellow
Merck
14 · 14,6495

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 2% (1 of 49) of reports.

Danger

H301 (89.8%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester, monohydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (89.8%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Nicardipine hydrochloride

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1/PG 3
hs_code
2933399090
RTECS-Nr.
US7972100
risk_code
23/24/25
Toxizität
LD50 in male, female rats (mg/kg): 634, 557 orally; 18.1, 25.0 i.v.; in male, female mice: 634, 650 orally; 20.7, 19.9 i.v. (Odani, Sado)

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 2 Einträge

NICARDIPINE HYDROCHLORIDE

Dihydropyridines [CS]; Cytochrome P450 2C8 Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]; Calcium Channel Antagonists [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

MeSH Pharmacological Classification · 3 Einträge

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Drugs used to cause dilation of the blood vessels.

Anwendungen · 2 Einträge

BeschreibungNicardipine is a dihydropyridine L-type calcium channel antagonist that displays antihypertensive and antianginal activity. It is reported to inhibit adenosine A1, A2A, and A3 receptors with Ki values of 19.6, 63.8, and 3.25 μM, respectively, and can inhibit cytochrome P450 3A4 catalytic activity with an IC50 value of 0.148 μM. Additionally, nicardipine has been shown to activate transient receptor potential A1 channels, producing an increase in Ca2+ (EC50 = 0.5 μM).

VerwendenDihydropyridine calcium channel blocker. Antianginal; antihypertensive

Anbieter50 Anbieter

北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shandong chuangyingchemical Co., Ltd.18853181302 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]

Zugehörige Reaktionen

4

Verknüpfte Notizen

Wird geladen…